All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • JNJ-101556143Phase 32 trials

    Johnson & Johnson (Janssen) · Prostatic Neoplasms

  • JNJ-90301900NBTXR3, Functionalized hafnium oxide nanoparticlesPhase 32 trials

    Johnson & Johnson (Janssen) · Carcinoma, Squamous Cell, Carcinoma, Non-Small-Cell Lung

  • JS105Phase 32 trials

    Risen (Suzhou) Pharma Tech Co., Ltd. · Advanced Solid Tumors, Breast Cancer

  • JYP0322Phase 32 trials

    Guangzhou JOYO Pharma Co., Ltd · Non Small Cell Lung Cancer, NSCLC (Advanced Non-small Cell Lung Cancer)

  • LAM561Phase 32 trials

    Laminar Pharmaceuticals · Primary Glioblastoma, Glioblastoma Multiforme, High-grade Glioma

  • LB1410Phase 32 trials

    L & L Bio Co., Ltd., Ningbo, China · Solid Tumor, Cervical Cancer

  • LB4330Phase 32 trials

    L & L Bio Co., Ltd., Ningbo, China · Solid Tumor, Cervical Cancer

  • NaporafenibLXH254, ERAS-254Phase 32 trials

    Novartis · Melanoma, Advanced or Metastatic NRAS-mutant Melanoma

  • NeladalkibNVL-655Phase 32 trials

    Nuvalent Inc. · Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive, Locally Advanced Solid Tumor

  • NP-G2-044PrilukaePhase 32 trials

    Novita Pharmaceuticals, Inc. · Platinum-resistant Ovarian Cancer, Advanced or Metastatic Solid Tumor Malignancies

  • NuvastaticPhase 32 trials

    Natureceuticals Sdn Bhd · Fatigue, Colon Cancer, Breast Neoplasms

  • Nuvastatic 300Phase 32 trials

    Natureceuticals Sdn Bhd · Fatigue Related to Cancer Treatment, Colon Cancer, Breast Cancer

  • OBI-821OBI-833Phase 32 trials

    OBI Pharma, Inc · Triple Negative Breast Cancer, Non-small Cell Lung Cancer

  • OciperlimabBGB-A1217Phase 32 trials

    BeOne Medicines (BeiGene) · Non Small Cell Lung Cancer, Advanced Malignancies

  • of Physician's ChoicePhase 32 trials

    BriaCell Therapeutics Corporation · Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm

  • OSE2101Phase 32 trials

    OSE Immunotherapeutics · Patients With Non-Small Cell Lung Cancer, Solid Advanced Tumor, Lymphoma

  • PalazestrantOP-1250Phase 32 trials

    Olema Oncology, Inc. · Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer

  • PamiparibBGB-290Phase 32 trials

    BeOne Medicines (BeiGene) · Ovarian Cancer, Advanced Malignancies

  • PF-07248144Phase 32 trials

    Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • PF-08046054SGN-PDL1VPhase 32 trials

    Pfizer · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma

  • Precemtabart tocentecanPrecem-TcT, M9140Phase 32 trials

    EMD Serono Research & Development Institute, Inc. · Metastatic Colorectal Cancer, Solid Tumors, Gastric Cancer

  • QL0911Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Cancer Treatment-Induced Thrombocytopenia, Thrombocytopenia, Immune

  • QLS4131Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Malignant Plasma Cell Neoplasms, Relapsed or Refractory Multiple Myeloma

  • RC118RC118-ADCPhase 32 trials

    RemeGen Co., Ltd. · Advanced Solid Tumor, Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

  • RezvilutamidePhase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

  • RP2Phase 32 trials

    Replimune, Inc. · Hepatocellular Carcinoma, Biliary Tract Cancer, Metastatic Uveal Melanoma

  • RYZ101Phase 32 trials

    RayzeBio, Inc. · Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer

  • SCTB14Phase 32 trials

    Sinocelltech Ltd. · Non-Small Cell Lung Carcinoma (NSCLC), Advanced Malignant Solid Tumours

  • SetidegrasibASP3082Phase 32 trials

    Astellas · Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma

  • SGT-003Phase 32 trials

    Solid Biosciences Inc. · Duchenne Muscular Dystrophy, Advanced Solid Tumor

  • SHR-2004Phase 32 trials

    Beijing Suncadia Pharmaceuticals Co., Ltd · Prevention of Arterial and Venous Thrombosis, Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

  • SHR-A1921Phase 32 trials

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Advanced Solid Tumors, Ovarian Cancer

  • SugemalimabPhase 32 trials

    Akeso · NSCLC (Non-small Cell Lung Cancer), Extranodal NK/T-cell Lymphoma

  • SV-BR-1-GMthe Bria-IMTPhase 32 trials

    BriaCell Therapeutics Corporation · Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm

  • TGRX-326once a dayPhase 32 trials

    Shenzhen TargetRx Co., Ltd. · Non-small Cell Lung Cancer, Non Small Cell Lung Cancer

  • tirapazaminePhase 32 trials

    Zhejiang Raygene Pharmaceuticals Co., Ltd · HCC, Hepatocellular Carcinoma, Gastrointestinal Cancer Metastatic

  • TOL2506Phase 32 trials

    Tolmar Inc. · Breast Cancer

  • TPST-1120Phase 32 trials

    Roche (Genentech) · Advanced Liver Cancers, Hepatocellular Carcinoma (HCC)

  • TQB2450Phase 32 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Endometrial Cancer, Non Small Cell Lung Cancer

  • TQB2868Phase 32 trials

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Pancreatic Neoplasms, Metastatic Pancreatic Ductal Adenocarcinoma

  • TQB3454Phase 32 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Advanced Solid Tumors, Biliary Carcinoma

  • TR115Phase 32 trials

    Tarapeutics Science Inc. · Ovarian Clear Cell Carcinoma, Endometrial Cancer, Stomach Cancer Recurrent

  • TunlametinibPhase 32 trials

    Shanghai Kechow Pharma, Inc. · Colorectal Cancer Metastatic, Melanoma

  • TuvonralimabPhase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer, Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

  • UliledlimabPhase 32 trials

    TJ Biopharma Co., Ltd. · Non Small Cell Lung Cancer

  • US-sourced KeytrudaPhase 32 trials

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer

  • Sichuan Baili Pharmaceutical Co., Ltd. · Squamous Non-small-cell Lung Cancer, Non-squamous Non-small Cell Lung Cancer

  • VepugratinibLY3866288Phase 32 trials

    Eli Lilly · Urinary Bladder Neoplasms, Urologic Neoplasms, Receptor, Fibroblast Growth Factor, Type 3

  • VT3989Phase 32 trials

    Vivace Therapeutics, Inc · Pleural Mesothelioma, Mesothelioma, Solid Tumor, Adult

  • XaluritamigAMG 509Phase 32 trials

    Amgen · Metastatic Castration-resistant Prostate Cancer

NewerPage 6 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.